Human Galectin-1 (GAL1) recombinant protein

Reference:
Size

100ug, 50ug

Brand

Product type

Host Species

Applications

,

Product nameHuman Galectin-1 (GAL1) recombinant protein
Uniprot IDP09382
Uniprot linkhttp://www.uniprot.org/uniprot/P09382
Origin speciesHomo sapiens (Human)
Expression systemProkaryotic expression
SequenceMACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFDLEHHHHHH
Molecular weight15.61kDa
Protein delivered with Tag?Yes
Purity estimated80%
Buffer50 mM Tris-HCl pH 8, 150 mM NaCl
FormLyophilized
Delivery conditionDry Ice
Delivery lead time in business days5-7
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesEscherichia coli (E.coli)
ApplicationsELISA,WB
Fragment TypeFull-length
Aliases /SynonymsLGALS1, GBP, HLBP14, Galaptin, Lectin,Galactoside-Binding Soluble 1, 14 kDa laminin-binding protein, Lactose-binding lectin 1, Putative MAPK-activating protein PM12, S-Lac lectin
ReferencePX-P4049
NoteFor research use only

Description of Human Galectin-1 (GAL1) recombinant protein

General Information about Human Galectin-1 (GAL1) recombinant protein

Galectin-1 (Gal-1, GAL1) is a member of galectin Galectin is a type of animal lectin. Affinity and significant sequence similarity in carbohydrates. in the place. It is a homodimer with a molecular weight subunit of 14.5 kDa and each subunit contains six cysteine ​​residues. Cysteine ​​residues must be in the free state to maintain a molecular structure that can show readability. This endogenous lectin is widely expressed at the sites of inflammation and tumor growth and is considered an attractive immunosuppressant, which can restore tolerance and homeostasis of immune cells in autoimmune and inflammatory environments. On the other hand, galectin-1 contributes to different steps in tumor progression, including tumor cell adhesion, migration, and immune activation, indicating that galectin-1 blockade may generate benefits in the treatment of cancer. Cancer. Several potential glycoprotein ligands of galectin-1 have been identified, including lysosomal membrane glycoprotein and fibronectin, laminin, and CD43 and CD45 T-cell glycoprotein. Evidence shows that Gal-1 and its ligands are one of the main regulators of the immune response, such as T cell homeostasis and survival, T cell immune diseases, inflammation and allergies, and host interactions. -pathogen.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Human Galectin-1 (GAL1) recombinant protein”

Your email address will not be published. Required fields are marked *

Related products

Galegenimab Biosimilar – Anti-HTRA mAb – Research Grade
Biosimilar

Galegenimab Biosimilar – Anti-HTRA mAb – Research Grade

PX-TA1771 400€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products